← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 27, 2018Last known activity
Mar 10, 2025
Timeline
2010s
- Jun 1, 2013
CRISPR Therapeutics— Founded
Drugs by trial phase (8 distinct, 16 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (26)
- NCT06925542Lead sponsorPhase 1Mar 10, 2025
- NCT06492304Lead sponsorPhase 1/Phase 2Aug 13, 2024
- NCT06492304OfficialPhase 1/Phase 2Aug 13, 2024
- NCT05795595Study directorPhase 1/Phase 2Mar 13, 2023
- NCT05795595Lead sponsorPhase 1/Phase 2Mar 13, 2023
- NCT05643742Lead sponsorPhase 1/Phase 2Jan 31, 2023
- NCT05643742Study directorPhase 1/Phase 2Jan 31, 2023
- NCT05565248Lead sponsorPhase 1/Phase 2Nov 30, 2022
- NCT05565248Study directorPhase 1/Phase 2Nov 30, 2022
- NCT05477563CollaboratorPhase 3Aug 2, 2022
- NCT05356195CollaboratorPhase 3May 3, 2022
- NCT05329649CollaboratorPhase 3May 2, 2022
- NCT05210530Study directorPhase 1Jan 24, 2022
- NCT05210530Lead sponsorPhase 1Jan 24, 2022
- NCT04208529CollaboratorPhase 3Jan 20, 2021
Details
- Founded
- Cambridge, MA, US Jun 1, 2013
- Last known activity
- Mar 10, 2025